Cell-selective modRNA translation system (IMAGE)
Caption
Researchers at the Icahn School of Medicine at Mount Sinai built an mRNA system that switches on therapeutic genes preferentially in targeted cells for greater precision and safety.
Credit
Mount Sinai Health System
Usage Restrictions
May only be used within the context of this news.
License
Original content